On November 13, 2013, Wikileaks obtained and published a copy of the consolidated IP negotiating chapter for the Trans-Pacific Partnership Agreement (TPP). This leak has allowed the public to learn what is in the text, including about the reported five country counterproposal to the United States’ proposal on pharmaceuticals and medicines.
KEI Comments on the August 30, 2013 version of the TPP IP Chapter
For more information, contact James Love, mailto:james.love@keionline.org, mobile +1.202.361.3040.
In a decision dated November 1, 2013, and signed by NIH Director Francis Collins, the NIH has rejected the 2012 petition to the NIH to uses its powers under the Bayh-Dole Act to protect U.S. consumers from high prices and restrictive licensing of NIH funded inventions.
 |
| Thaddeus Burns of GE spent months trying to derail the WIPO treaty for the blind negotiations |
 |
| The letter opposing the treaty for the blind was signed by TABC Director General Tim Bennett |
We just ran across this mean spirited letter by the Trans-Atlantic Business Council (TABC), a group that describes itself as follows:
The October 25, 2012 NIH March-In Request for ritonavir is now more than one year old, and the NIH has not decided to grant a hearing or reject the petition.
More information about the March-In request is available here:
https://www.keionline.org/2012ritonavir
(revised October 25, 2013)
KEI has asked 21 persons following the TPP IPR negotiations, what they thought of four of the USTR negotiators, including:
At the request of the European Union, Jamaica, Mexico and the United States of America, the topic of “Intellectual Property and Sports” was placed for discussion at the World Trade Organization’s (WTO) October 2013 session of the Council for TRIPS (TRIPS Council).
Introduction
I. Scope of Patentability
II. Evergreening Patents
III. Patent Trolls
IV. Presumption of Validity
V. Injunctions
VI. Exclusive Rights Over Test Data
VII. Patent Linkage
VIII. Delinkage/Positive Agenda
Conclusion
Introduction
Continue Reading